|
2025-04-11 |
2025-04-09 |
A
Achat
|
ADAR1 Capital Management, LLC
Actionnaire important
|
74 333
+1.7%
10,33
767 860 USD
|
74 333
+1.7%
|
10,33
|
767 860 USD
|
|
|
2025-04-11 |
2025-04-09 |
A
Achat
|
ADAR1 Capital Management, LLC
Actionnaire important
|
500 000
+13.1%
10,33
5 165 000 USD
|
500 000
+13.1%
|
10,33
|
5 165 000 USD
|
|
|
2025-04-11 |
2025-04-09 |
A
Achat
|
ADAR1 Capital Management, LLC
Actionnaire important
|
325 000
+9.3%
9,86
3 203 525 USD
|
325 000
+9.3%
|
9,86
|
3 203 525 USD
|
|
|
2025-04-11 |
2025-04-09 |
A
Achat
|
ADAR1 Capital Management, LLC
Actionnaire important
|
16 365
+2.3%
9,40
153 752 USD
|
16 365
+2.3%
|
9,40
|
153 752 USD
|
|
|
2025-04-11 |
2025-04-09 |
A
Achat
|
ADAR1 Capital Management, LLC
Actionnaire important
|
18 560
+0.5%
9,40
174 375 USD
|
18 560
+0.5%
|
9,40
|
174 375 USD
|
|
|
2024-08-15 |
2024-08-13 |
V
Vente
|
GORDON CARL L
Administrateur non-exécutif
|
29 400
-19.7%
44,01
1 293 894 USD
|
29 400
-19.7%
|
44,01
|
1 293 894 USD
|
|
|
2024-08-15 |
2024-08-13 |
V
Vente
|
GORDON CARL L
Administrateur non-exécutif
|
220 600
-19.7%
44,01
9 708 606 USD
|
220 600
-19.7%
|
44,01
|
9 708 606 USD
|
|
|
2024-08-15 |
2024-08-13 |
V
Vente
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
|
29 400
-19.7%
44,01
1 293 894 USD
|
29 400
-19.7%
|
44,01
|
1 293 894 USD
|
|
|
2024-08-15 |
2024-08-13 |
V
Vente
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
|
220 600
-19.7%
44,01
9 708 606 USD
|
220 600
-19.7%
|
44,01
|
9 708 606 USD
|
|
|
2024-01-08 |
2023-11-04 |
VP
Vente planifiée
|
Regnante Keith
Chief Financial Officer
Dirigeant
|
40 000
-100.0%
45,29
1 811 600 USD
|
40 000
-100.0%
|
45,29
|
1 811 600 USD
|
|
|
2023-06-12 |
2023-06-09 |
VP
Vente planifiée
|
Regnante Keith
Chief Financial Officer
Dirigeant
|
2 579
-100.0%
47,25
121 858 USD
|
2 579
-100.0%
|
47,25
|
121 858 USD
|
|
|
2023-06-12 |
2023-06-09 |
VP
Vente planifiée
|
Regnante Keith
Chief Financial Officer
Dirigeant
|
1 428
-35.6%
46,46
66 345 USD
|
1 428
-35.6%
|
46,46
|
66 345 USD
|
|
|
2023-06-12 |
2023-06-09 |
VP
Vente planifiée
|
Regnante Keith
Chief Financial Officer
Dirigeant
|
15 993
-80.0%
45,03
720 165 USD
|
15 993
-80.0%
|
45,03
|
720 165 USD
|
|
|
2023-06-12 |
2023-06-08 |
VP
Vente planifiée
|
Regnante Keith
Chief Financial Officer
Dirigeant
|
2 699
-100.0%
48,65
131 306 USD
|
2 699
-100.0%
|
48,65
|
131 306 USD
|
|
|
2023-06-12 |
2023-06-08 |
VP
Vente planifiée
|
Regnante Keith
Chief Financial Officer
Dirigeant
|
17 301
-86.5%
47,66
824 566 USD
|
17 301
-86.5%
|
47,66
|
824 566 USD
|
|
|
2022-07-19 |
2022-07-15 |
VP
Vente planifiée
|
Lachey Jennifer
Chief Scientific Officer
Dirigeant
|
46 034
-32.6%
30,00
1 381 020 USD
|
46 034
-32.6%
|
30,00
|
1 381 020 USD
|
|
|
2022-07-15 |
2022-07-13 |
VP
Vente planifiée
|
Lachey Jennifer
Chief Scientific Officer
Dirigeant
|
1 916
-2.0%
30,00
57 480 USD
|
1 916
-2.0%
|
30,00
|
57 480 USD
|
|
|
2022-05-13 |
2022-05-11 |
VP
Vente planifiée
|
Lachey Jennifer
Chief Scientific Officer
Dirigeant
|
16
-0.0%
45,45
727 USD
|
16
-0.0%
|
45,45
|
727 USD
|
|
|
2022-05-13 |
2022-05-11 |
VP
Vente planifiée
|
Lachey Jennifer
Chief Scientific Officer
Dirigeant
|
223
-0.3%
44,23
9 863 USD
|
223
-0.3%
|
44,23
|
9 863 USD
|
|
|
2022-05-13 |
2022-05-11 |
VP
Vente planifiée
|
Lachey Jennifer
Chief Scientific Officer
Dirigeant
|
719
-0.8%
43,32
31 147 USD
|
719
-0.8%
|
43,32
|
31 147 USD
|
|
